These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Association between daptomycin susceptibility and teicoplanin resistance in Staphylococcus epidermidis. Watanabe S; Kawakami Y; Kimura H; Murakami S; Miyamoto H; Takatori S; Suemori K; Tanaka M; Tanaka A; Tanaka K; Tauchi H; Maki J; Araki H; Yamaguchi T Sci Rep; 2019 Dec; 9(1):18533. PubMed ID: 31811214 [TBL] [Abstract][Full Text] [Related]
9. Characterization of Teicoplanin Nonsusceptible Staphylococcus epidermidis Clinical Isolates Belonging Predominantly to ST267. Liu C; Zhang F; Chen C; Feng X; Xu M; Guo X; Sun J; Li G; Zhu P; Zeng L; Xu H; Wang H; Li X; Ming L Microb Drug Resist; 2017 Apr; 23(3):321-327. PubMed ID: 27314582 [TBL] [Abstract][Full Text] [Related]
10. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics]. Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772 [TBL] [Abstract][Full Text] [Related]
13. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro. Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358 [TBL] [Abstract][Full Text] [Related]
14. In-vitro selection of resistance to vancomycin and teicoplanin in Enterococcus faecium and Enterococcus faecalis compared with Staphylococcus epidermidis. Markopulos E; Graninger W; Georgopoulos A J Antimicrob Chemother; 1998 Jan; 41(1):43-7. PubMed ID: 9511036 [TBL] [Abstract][Full Text] [Related]
15. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital. Sloos JH; van de Klundert JA; Dijkshoorn L; van Boven CP J Antimicrob Chemother; 1998 Dec; 42(6):787-91. PubMed ID: 10052903 [TBL] [Abstract][Full Text] [Related]
16. The emergence of Staphylococcus epidermidis simultaneously nonsusceptible to linezolid and teicoplanin in China. Liu C; Chen C; Ye Y; Li X; Sun J; Xu L; Ming L Diagn Microbiol Infect Dis; 2020 Feb; 96(2):114956. PubMed ID: 31813640 [TBL] [Abstract][Full Text] [Related]
17. Draft genome sequences of three clinical isolates of teicoplanin-resistant Staphylococcus epidermidis from patients without prior exposure to glycopeptide antibiotics. Vimberg V; Zieglerova L; Závora J; Šemberová L; Prásilová J; Adámková V; Novotna GB J Glob Antimicrob Resist; 2019 Mar; 16():251-253. PubMed ID: 30797086 [TBL] [Abstract][Full Text] [Related]
18. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations. Low DE; McGeer A; Poon R Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of aptamer targeted teicoplanin encapsulated PLGA nanoparticles for Staphylococcus aureus strains. Ucak S; Sudagidan M; Borsa BA; Mansuroglu B; Ozalp VC World J Microbiol Biotechnol; 2020 Apr; 36(5):69. PubMed ID: 32333113 [TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide. Biavasco F; Vignaroli C; Lupidi R; Manso E; Facinelli B; Varaldo PE Antimicrob Agents Chemother; 1997 Oct; 41(10):2165-72. PubMed ID: 9333042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]